Invitrogen, Genetic Applications Settle Patent Infringement Dispute | GenomeWeb
NEW YORK (GenomeWeb News) – Invitrogen and Genetic Applications have settled a lawsuit that Genetic Applications filed last year alleging Invitrogen’s infringement of a patent covering gene-transfer technology.
According to court documents, the US District Court for the Eastern District of Texas dismissed the case on Dec. 10 in response to a request from Genetic Applications. Terms of the settlement were not disclosed. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.